Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Hepatitis C Virus Infection in ESKD Patients.

× No keyword cloud information.

10 in total

1. Safety and efficacy of sofosbuvir-containing regimens in hepatitis C-infected patients with impaired renal function.

Authors: Varun Saxena; Farrukh M Koraishy; Meghan E Sise; Joseph K Lim; Monica Schmidt; Raymond T Chung; Annmarie Liapakis; David R Nelson; Michael W Fried; Norah A Terrault
Journal: Liver Int Date: 2016-03-24 Impact factor: 5.828

2. Transplantation of kidneys from hepatitis C-positive donors into hepatitis C virus-infected recipients followed by early initiation of direct acting antiviral therapy: a single-center retrospective study.

Authors: Kalyan R Bhamidimarri; Marco Ladino; Fernando Pedraza; Giselle Guerra; Adela Mattiazzi; Linda Chen; Gaetano Ciancio; Warren Kupin; Paul Martin; George Burke; David Roth
Journal: Transpl Int Date: 2017-05-02 Impact factor: 3.782

3. Mortality, Hospitalization, and Quality of Life among Patients with Hepatitis C Infection on Hemodialysis.

Authors: David A Goodkin; Brian Bieber; Michel Jadoul; Paul Martin; Eiichiro Kanda; Ronald L Pisoni
Journal: Clin J Am Soc Nephrol Date: 2016-12-01 Impact factor: 8.237

4. Efficacy of Direct-Acting Antiviral Combination for Patients With Hepatitis C Virus Genotype 1 Infection and Severe Renal Impairment or End-Stage Renal Disease.

Authors: Paul J Pockros; K Rajender Reddy; Parvez S Mantry; Eric Cohen; Michael Bennett; Mark S Sulkowski; David E Bernstein; Daniel E Cohen; Nancy S Shulman; Deli Wang; Amit Khatri; Manal Abunimeh; Thomas Podsadecki; Eric Lawitz
Journal: Gastroenterology Date: 2016-03-11 Impact factor: 22.682

5. Use of HCV+ Donors Does Not Affect HCV Clearance With Directly Acting Antiviral Therapy But Shortens the Wait Time to Kidney Transplantation.

Authors: Deirdre Sawinski; Nikunjkumar Patel; Brenda Appolo; Roy Bloom
Journal: Transplantation Date: 2017-05 Impact factor: 4.939

6. Hepatitis C infection is very rarely treated among hemodialysis patients.

Authors: David A Goodkin; Brian Bieber; Brenda Gillespie; Bruce M Robinson; Michel Jadoul
Journal: Am J Nephrol Date: 2013-10-29 Impact factor: 3.754

Review 7. Hepatitis C Virus Infection in Chronic Kidney Disease.

Authors: Marco Ladino; Fernando Pedraza; David Roth
Journal: J Am Soc Nephrol Date: 2016-04-19 Impact factor: 10.121

8. Glecaprevir and Pibrentasvir in Patients with HCV and Severe Renal Impairment.

Authors: Edward Gane; Eric Lawitz; David Pugatch; Georgios Papatheodoridis; Norbert Bräu; Ashley Brown; Stanislas Pol; Vincent Leroy; Marcello Persico; Christophe Moreno; Massimo Colombo; Eric M Yoshida; David R Nelson; Christine Collins; Yang Lei; Matthew Kosloski; Federico J Mensa
Journal: N Engl J Med Date: 2017-10-12 Impact factor: 91.245

Review 9. Opportunities for treatment of the hepatitis C virus-infected patient with chronic kidney disease.

Authors: Marco Ladino; Fernando Pedraza; David Roth
Journal: World J Hepatol Date: 2017-07-08

10. Grazoprevir plus elbasvir in treatment-naive and treatment-experienced patients with hepatitis C virus genotype 1 infection and stage 4-5 chronic kidney disease (the C-SURFER study): a combination phase 3 study.

Authors: David Roth; David R Nelson; Annette Bruchfeld; AnnMarie Liapakis; Marcelo Silva; Howard Monsour; Paul Martin; Stanislas Pol; Maria-Carlota Londoño; Tarek Hassanein; Philippe J Zamor; Eli Zuckerman; Shuyan Wan; Beth Jackson; Bach-Yen Nguyen; Michael Robertson; Eliav Barr; Janice Wahl; Wayne Greaves
Journal: Lancet Date: 2015-10-05 Impact factor: 202.731

10 in total